Beijing Hospital

Running trials

• Not yet recruiting

  An Open-label, Dose-escalation Phase Ib Study of EA5 Injection in Adults With Anti-AChR Antibody-Positive Generalized Myasthenia Gravis

  NCT07818291· Phase 1· Source

• Recruiting

  Chiglitazar Added to SGLT-2 Inhibitors for Type 2 Diabetes

  NCT07580638· Source

• Recruiting

  Phase II Study of Subretinal JWK001 for Neovascular Age-Related Macular Degeneration

  NCT07776522· Phase 2· Source

• Recruiting

  Cardiopulmonary Exercise Testing-based High-intensity Interval Training For Improving Heart Failure With Preserved Ejection Fraction

  NCT07693049· Source

• Not yet recruiting

  Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease

  NCT07741045· Phase 3· Source

• Recruiting

  A Phase IIa Study of JAB-8263 in Patients With Active Rheumatoid Arthritis

  NCT07684157· Phase 2· Source

• Enrolling by invitation

  Research Study to Examine Blood Sugar Control, Treatment Satisfaction and Adherence in People With Type 2 Diabetes After Switching From Daily Basal Insulin to Once-weekly Insulin Icodec

  NCT07658417· Source

• Recruiting

  Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation

  NCT07444372· Source

• Recruiting

  Radiotherapy After Prostatectomy for Node Positive Prostate Cancer

  NCT07477626· Phase 3· Source

• Recruiting

  5T MRI and Metabolomics-Based Hemorrhage Risk Prediction in Moyamoya Disease

  NCT07781579· Source

• Recruiting

  A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer

  NCT07339267· Phase 1· Source

• Recruiting

  Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR)

  NCT07317934· Phase 3· Source

• Recruiting

  A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG)

  NCT07249632· Phase 3· Source

• Enrolling by invitation

  Development and Validation of a Non-Invasive AI Diagnostic Model for Prostate Cancer Using Multiparametric MRI and PSMA PET/CT

  NCT07690306· Source

• Not yet recruiting

  A Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the Efficacy, Durability, and Safety of Aflibercept 8mg in Different Treatment Regimens in Chinese Patients With Polypoidal Choroidal Vasculopathy (PCV)

  NCT07365371· Phase 4· Source

• Active, not recruiting

  A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE

  NCT07245407· Source

• Recruiting

  CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

  NCT07207811· Phase 3· Source

• Not yet recruiting

  A Phase 3 Study of HS-20094 in Patients With T2DM Inadequately Controlled With Diet and Exercise Alone

  NCT07156500· Phase 3· Source

• Not yet recruiting

  Mazdutide as Adjuvant Therapy Following Sleeve Gastrectomy in Severe Obesity

  NCT07135141· Source

• Recruiting

  A Study of Pegmolesatide of in Dialysis Chronic Kidney Disease (CKD) Patients With Anemia Treated With Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI)

  NCT07136792· Source

• Recruiting

  A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity

  NCT06974851· Phase 3· Source

• Active, not recruiting

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· Phase 3· Source

• Recruiting

  QA108 Phase III Study in Subjects With Intermediate AMD

  NCT07189169· Phase 3· Source

• Recruiting

  Safety and Efficacy of Oral HX9428 Tablets in Subjects With Wet Age-related Macular Degeneration (wAMD)

  NCT07185841· Phase 1/2· Source

• Not yet recruiting

  The Safety, Feasibility and Efficacy of NouvNeu001 for Parkinson's Disease

  NCT07028632· Phase 2· Source

• Recruiting

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· Phase 3· Source

• Recruiting

  Safety and Efficacy of Mesenchymal Stromal Cells (Amimestrocel ) in Diabetic Kidney Disease

  NCT06969807· Phase 2· Source

• Active, not recruiting

  A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease （MAFLD）

  NCT06884293· Phase 3· Source

• Recruiting

  A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

  NCT06346600· Source

• Not yet recruiting

  A Multicenter, Open-label, Prospective Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Participants With Suspected Recurrent Prostate Cancer After Radical Treatment

  NCT06922929· Phase 3· Source

• Not yet recruiting

  Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer.

  NCT06922903· Phase 3· Source

• Active, not recruiting

  Effect of CGM on Glucose Control in Non-insulin-treated Patients With Type 2 Diabetes Mellitus

  NCT06587438· Source

• Recruiting

  Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

  NCT06712316· Phase 2/3· Source

• Active, not recruiting

  A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China

  NCT06666855· Phase 3· Source

• Recruiting

  Seniors Integrated Longitudinal cardioVascular Evaluation of Coronary Heart Disease: a Multicenter, Prospective Registry in China (SILVER-China)

  NCT06880575· Source

• Recruiting

  A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  NCT06585787· Phase 3· Source

• Recruiting

  A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  NCT06452277· Phase 3· Source

• Active, not recruiting

  A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

  NCT06456580· Phase 3· Source

• Not yet recruiting

  Henagliflozin's Impact on Prediabetes Remission

  NCT06448130· Phase 4· Source

• Recruiting

  Identification for High Risk of Coronary Heart Disease Based on Quantitative Analysis of Fundus Vessels and Metabolic Molecules

  NCT07773064· Source

• Recruiting

  Evaluate the Safety and Efficacy of Tafasitamab and Lenalidomide in Combination With Gemcitabine and Oxaliplatin Versus Rituximab in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

  NCT06521255· Phase 3· Source

• Recruiting

  Automated Echocardiographic Detection of Coronary Artery Disease Using Artificial Intelligence Methods

  NCT06314295· Source

• Recruiting

  ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC

  NCT06321081· Phase 2· Source

• Recruiting

  Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)

  NCT05986864· Phase 1/2· Source

• Recruiting

  Myasthenia Gravis Registry in China

  NCT06241521· Source

• Recruiting

  The Safety, Tolerability and Efficacy of NouvNeu001 for Parkinson's Disease

  NCT06167681· Phase 1/2· Source

• Recruiting

  Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer

  NCT05950945· Phase 3· Source

• Recruiting

  A Study to Evaluate the Efficacy and Safety of SHR-1703 in Subjects With Eosinophilic Granulomatosis With Polyangiitis （EGPA）

  NCT05979051· Phase 2/3· Source

• Recruiting

  An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease

  NCT05908695· Phase 4· Source

• Recruiting

  A Study of BL-M11D1 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

  NCT05924750· Phase 1· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Macular degeneration7 recruiting
• Prostate cancer6 recruiting
• Myasthenia gravis4 recruiting
• Type 2 diabetes4 recruiting
• Coronary artery disease3 recruiting
• Heart failure3 recruiting
• Obesity3 recruiting
• Parkinson disease3 recruiting
• Alzheimer disease2 recruiting
• Chronic kidney disease2 recruiting
• Liver and biliary tract cancer2 recruiting
• Lung cancer2 recruiting
• Acute myeloid leukemia1 recruiting
• Amyloidosis1 recruiting
• ANCA-associated vasculitis1 recruiting
• Atrial fibrillation1 recruiting
• Bladder cancer1 recruiting
• Childhood cancers1 recruiting
• Colorectal cancer1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Kidney cancer1 recruiting
• Metastatic breast cancer1 recruiting
• Osteoporosis1 recruiting
• Rheumatoid arthritis1 recruiting
• Schizophrenia1 recruiting
• Stroke1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Safety, Tolerability, and Pharmacokinetics of a Single or Multiple Ascending Doses of CPX101

  NCT06545162· Phase 1· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of HRG2010 in Parkinson's Disease With Motor Fluctuations

  NCT06596876· Phase 3· Source

• Completed

  A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Metformin

  NCT06589765· Phase 3· Source

• Completed

  A Research Study Looking at a Single Dose of Etavopivat in Healthy Chinese Participants

  NCT06581627· Phase 1· Source

• Completed

  A Study to Learn More About How Well 8 Milligram Aflibercept Works and How Safe it is in Chinese Participants With Diabetic Macular Edema

  NCT06422507· Phase 3· Source

• Completed

  A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor

  NCT06109311· Phase 3· Source

• Completed

  A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis

  NCT06068465· Phase 3· Source

• Completed

  Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 Diabetes

  NCT06739044· Phase 3· Source

• Completed

  A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range

  NCT06041217· Phase 3· Source

• Completed

  A Study to Evaluate the Safety and Effectiveness of Trastuzumab Emtansine (T-DM1) as Therapy in Chinese Participants With HER2 Positive Advanced Breast Cancer

  NCT05945927· Source

• Completed

  A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone

  NCT05971940· Phase 3· Source

• Completed

  A SAD Study of ZT002 Injection in Healthy Participants

  NCT06423872· Phase 1· Source

• Completed

  A Study of Dimethyl Fumarate (DMF) in Relapsing Forms of Multiple Sclerosis (RMS) Participants in China

  NCT05658484· Phase 4· Source

• Completed

  Pharmacokinetics,Pharmacodynamics,Efficacy and Safety of HRG2010 in Parkinson's Disease Patients With Motor Fluctuations

  NCT06614153· Phase 2· Source

• Completed

  Study of Telitacicept in Generalized Myasthenia Gravis

  NCT05737160· Phase 3· Source

• Completed

  Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T2DM

  NCT05417841· Source

• Completed

  A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes

  NCT05691712· Phase 3· Source

• Completed

  A Study to Compare the PK , Safety, Tolerability, and Immunogenicity of HLX15 With Daratumumab in Male Subjects

  NCT05679258· Phase 1· Source

• Completed

  A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

  NCT05595642· Phase 3· Source

• Completed

  A Phase III Study for 601 Versus Ranibizumab in Patients With Vision Loss

  NCT05520177· Phase 3· Source

• Completed

  Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate

  NCT05590793· Phase 3· Source

• Completed

  Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration

  NCT05439629· Phase 3· Source

• Completed

  A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema

  NCT06850922· Phase 1/2· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of HLX14 vs. Denosumab Prolia® in Postmenopausal Women With Osteoporosis at High Risk of Fracture

  NCT05352516· Phase 3· Source

• Completed

  A Research Study of How the Medicine Ziltivekimab Works in the Body of Chinese Men and Women With Kidney Disease and Inflammation

  NCT05379829· Phase 1· Source

• Completed

  Treatment of Relapsed or Refractory Diffuse Large B Cell Lymphoma With Ociperlimab (BGB-A1217) in Combination With Tislelizumab (BGB-A317) or Rituximab

  NCT05267054· Phase 1/2· Source

• Completed

  A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80

  NCT05348785· Phase 2· Source

• Completed

  Chinese Osteoporotic Fracture Registration Network Platform

  NCT05339425· Source

• Completed

  A Study of Diroximel Fumarate (DRF) in Adult Participants From the Asia-Pacific Region With Relapsing Forms of Multiple Sclerosis (RMS)

  NCT05083923· Phase 3· Source

• Terminated

  Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)

  NCT04968184· Phase 3· Source

• Completed

  Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction

  NCT04944706· Phase 2· Source

• Completed

  Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension

  NCT05359068· Phase 3· Source

• Completed

  Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China

  NCT04747496· Source

• Completed

  Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer

  NCT04736199· Phase 3· Source

• Completed

  Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye

  NCT04423718· Phase 3· Source

• Completed

  A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)

  NCT04108208· Phase 4· Source

• Completed

  A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)

  NCT03940703· Phase 2· Source

• Completed

  Study of Platinum Plus Etoposide With or Without Tislelizumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer

  NCT04005716· Phase 3· Source

• Completed

  Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment

  NCT04085276· Phase 3· Source

• Completed

  DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]

  NCT03529110· Phase 3· Source

• Terminated

  A Phase III Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Neuromyelitis Optica Spectrum Disorders

  NCT03330418· Phase 3· Source

• Completed

  Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

  NCT02003924· Phase 3· Source